常见甲状腺疾病与系统免疫炎症指数研究进展
Research Progress of Common Thyroid Diseases and Systemic Immune Inflammation Index
DOI: 10.12677/ACM.2022.125680, PDF,   
作者: 宋 晨, 赵海宁*:青海大学附属医院乳腺甲状腺肿瘤外科,青海 西宁
关键词: 甲状腺疾病甲状腺癌炎症系统免疫炎症指数SIIThyroid Disease Thyroid Cancer Inflammation Systemic Immune Inflammation Index SII
摘要: 甲状腺疾病是常见的内分泌系统疾病,常见的甲状腺疾病有甲状腺结节、甲状腺炎、甲状腺功能亢进症、甲状腺功能减退症等。甲状腺肿瘤是一种最常见的内分泌和头颈肿瘤。DTC是恶性肿瘤里最常见的类型,虽发病率高,但早期病人预后好,虽说大部分甲状腺癌预后较好,但颈部淋巴结转移和远处转移依然常见。随着炎症反应和免疫反应在肿瘤的发生、发展的机制越来越清晰,本文就一些免疫因子与常见甲状腺疾病做一综述,为甲状腺肿瘤的良恶性鉴别及甲状腺肿瘤的诊断、预后等提供一些理论参考。
Abstract: Thyroid disease is a common endocrine system disease. The common thyroid diseases include thy-roid nodules, thyroiditis, Hyperthyroidism, hypothyroidism, etc. Thyroid tumor is the most common endocrine and head and neck tumor. DTC is the most common type of malignant tumor. Although the incidence rate is high, early patients have a good prognosis. Although most thyroid cancers have a good prognosis, neck lymph node metastasis and distant metastasis are still common. As the mechanism of inflammatory response and immune response in the occurrence and development of tumor become clearer and clearer. This article reviews some immune inflammatory factors and common thyroid diseases, and provides some theoretical references for the differentiation of benign and malignant thyroid tumors, diagnosis and prognosis of thyroid tumors.
文章引用:宋晨, 赵海宁. 常见甲状腺疾病与系统免疫炎症指数研究进展[J]. 临床医学进展, 2022, 12(5): 4700-4704. https://doi.org/10.12677/ACM.2022.125680

参考文献

[1] Singh, N., Baby, D., Rajguru, J.P., et al. (2019) Inflammation and Cancer. Annals of African Medicine, 18, 121-126. [Google Scholar] [CrossRef] [PubMed]
[2] Hu, B., Yang, X.R., Xu, Y., et al. (2014) Systemic Im-mune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma. Clinical Cancer Research, 20, 6212-6222. [Google Scholar] [CrossRef
[3] Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? Lancet, 357, 539-545. [Google Scholar] [CrossRef
[4] Diakos, C.I., Charles, K.A., Mcmillan, D.C., et al. (2014) Cancer-Related Inflammation and Treatment Effectiveness. The Lancet Oncology, 15, e493-e503. [Google Scholar] [CrossRef
[5] Grivennikov, S.I., Greten, F.R. and Karin, M. (2010) Im-munity, Inflammation, and Cancer. Cell, 140, 883-899. [Google Scholar] [CrossRef] [PubMed]
[6] Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. [Google Scholar] [CrossRef] [PubMed]
[7] Murata, M. (2018) Inflammation and Cancer. Environmental Health and Preventive Medicine, 23, Article No. 50. [Google Scholar] [CrossRef] [PubMed]
[8] Stotz, M., Pichler, M., Absenger, G., et al. (2014) The Preopera-tive Lymphocyte to Monocyte Ratio Predicts Clinical Outcome in Patients with Stage III Colon Cancer. British Journal of Cancer, 110, 435-440. [Google Scholar] [CrossRef] [PubMed]
[9] Kemal, Y., Yucel, I., Ekiz, K., et al. (2014) Elevated Serum Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios Could Be Useful in Lung Cancer Diagnosis. Asian Pacific Journal of Cancer Prevention, 15, 2651-2654. [Google Scholar] [CrossRef
[10] Sylman, J.L., Mitrugno, A., Atallah, M., et al. (2018) The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis. Frontiers in Oncology, 8, Article No. 78. [Google Scholar] [CrossRef] [PubMed]
[11] Dumitru, C.A., Lang, S. and Brandau, S. (2013) Modulation of Neutrophil Granulocytes in the Tumor Microenvironment: Mechanisms and Consequences for Tumor Progression. Sem-inars in Cancer Biology, 23, 141-148. [Google Scholar] [CrossRef] [PubMed]
[12] Gong, W., Yang, S., Yang, X., et al. (2016) Blood Preoper-ative Neutrophil-to-Lymphocyte Ratio Is Correlated with TNM Stage in Patients with Papillary Thyroid Cancer. Clinics, 71, 311-314. [Google Scholar] [CrossRef] [PubMed]
[13] Fridlender, Z.G., Sun, J., Kim, S., et al. (2009) Po-larization of Tumor-Associated Neutrophil Phenotype by TGF-Beta: “N1” versus “N2” TAN. Cancer Cell, 16, 183-194. [Google Scholar] [CrossRef] [PubMed]
[14] Stone, R.L., Nick, A.M., Mcneish, I.A., et al. (2012) Paraneoplastic Thrombocytosis in Ovarian Cancer. New England Journal of Medicine, 366, 610-618. [Google Scholar] [CrossRef
[15] Kono, S.A., Heasley, L.E., Doebele, R.C. and Camidge, D.R. (2012) Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non-Small Cell Lung Cancer. Current Cancer Drug Targets, 12, 107-123. [Google Scholar] [CrossRef] [PubMed]
[16] Baranyai, Z., Josa, V., Toth, A., et al. (2016) Paraneoplastic Thrombocytosis in Gastrointestinal Cancer. Platelets, 27, 269-275. [Google Scholar] [CrossRef] [PubMed]
[17] Agoston, A.T., Srivastava, A., Zheng, Y., et al. (2017) Paraneoplastic Thrombocytosis Is Associated with Increased Mortality and Increased Rate of Lymph Node Metastasis in Oesophageal Adenocarcinoma. Pathology, 49, 471-475. [Google Scholar] [CrossRef] [PubMed]
[18] 周文毓, 陈金婵, 惠宁. 治疗前血小板和淋巴细胞比值与宫颈癌新辅助化疗疗效及预后的相关性[J]. 中国肿瘤临床, 2014, 41(16): 1045-1048.
[19] Yang, J., Xu, H., Guo, X., et al. (2018) Pretreatment Inflammatory Indexes as Prognostic Predictors for Survival in Colorectal Cancer Patients Re-ceiving Neoadjuvant Chemoradiotherapy. Scientific Reports, 8, Article No. 3044. [Google Scholar] [CrossRef] [PubMed]
[20] Guo, L., Liu, S., Zhang, S., et al. (2015) C-Reactive Protein and Risk of Breast Cancer: A Systematic Review and Meta-Analysis. Scientific Reports, 5, Article No. 10508. [Google Scholar] [CrossRef] [PubMed]
[21] Kawai, M., Hirono, S., Okada, K.I., et al. (2019) Low Lymphocyte Mon-ocyte Ratio after Neoadjuvant Therapy Predicts Poor Survival after Pancreatectomy in Patients with Borderline Resectable Pancreatic Cancer. Surgery, 165, 1151-1160. [Google Scholar] [CrossRef] [PubMed]
[22] Ceylan, Y., Kuman-lioglu, K., Oral, A., et al. (2019) The Correlation of Clinicopathological Findings and Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Papillary Thyroid Carcinoma. Molecular Imaging and Radionuclide Therapy, 28, 15-20. [Google Scholar] [CrossRef] [PubMed]
[23] Manatakis, D.K., Tseleni-Balafouta, S., Tzelves, L., et al. (2018) Diagnostic Accuracy of Preoperative Neutrophil-to- Lymphocyte and Platelet-to-Lymphocyte Ratios in De-tecting Occult Papillary Thyroid Microcarcinomas in Benign Multinodular Goitres. Journal of Thyroid Research, 2018, Article ID: 3470429. [Google Scholar] [CrossRef] [PubMed]
[24] 赵跃, 黄景昊, 孙甲甲, 刘春蓉, 王宁, 孟震, 等. 术前NLR、PLR、SII与甲状腺乳头状癌临床病理特征的关系[J]. 中华全科医学, 2019, 17(5): 716-719+737.
[25] 赵跃, 郭永刚, 孙甲甲, 刘春蓉, 周广磊, 黄景昊, 等. 术前SII、NLR、PLR在分化型甲状腺癌中的诊断价值分析[J]. 兰州大学学报(医学版), 现代肿瘤医学, 2018, 44(6): 50-56.
[26] 刘芮吟, 张睿, 吴梦鸽, 孟艳飞, 吴华杰, 费继敏. 术前NLR联合SII在鉴别甲状腺良、恶性结节中的价值评估[J]. 肿瘤预防与治疗, 2020, 33(10): 877-884.
[27] Calapkulu, M., Sencar, M.E., Sakiz, D., et al. (2020) The Prognostic and Diagnostic use of Hematological Parameters in Subacute Thyroiditis Patients. Endocrine, 68, 138-143. [Google Scholar] [CrossRef] [PubMed]
[28] Ari, A. and Gunver, F. (2019) Comparison of Neutro-phil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Patients with Thyroiditis and Papillary Tumors. Journal of In-ternational Medical Research, 47, 2077-2083. [Google Scholar] [CrossRef] [PubMed]
[29] 顾雪疆, 吴森敏, 徐静, 洪逸莲, 杨丽娟, 林怡. 中性粒细胞/淋巴细胞比值和血小板/淋巴细胞比值在甲状腺毒症患者鉴别诊断中的意义[J]. 中华内分泌代谢杂志, 2017, 33(6): 491-496.